Streetbeat News

Products Services

AAPL

A woman from Utah accidentally swallowed one of her Apple Inc. AirPods, mistaking it for a vitamin. This incident is not isolated, with similar cases reported in Massachusetts and the UK. The woman was advised to let the device pass naturally.

Portfolio Pulse from Benzinga Neuro

September 13, 2023 | 2:13 pm

MSFT

Microsoft is investigating an incident affecting its Teams platform, with users potentially experiencing delays or failures in sending and receiving messages.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 2:13 pm

GRRR

Gorilla Technology Group has partnered with Protactics, a Latin-American security and defense solutions provider. The partnership will allow Protactics to provide sales and support for Gorilla's AI-based Video Analytics and Security Convergence solutions in certain Latin American markets, including Colombia, Mexico, and Venezuela.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:39 pm

AAPL

TSM

Taiwan Semiconductor Manufacturing Company (TSMC) has started mass production of 3nm process technology with Apple as its first customer. TSMC is preparing to fulfill more orders for 3nm chips from other key customers in 2024.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:36 pm

EPOW

Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) announced that it has applied for two more patents related to hard carbon composite materials. The company also reported that it was granted two new invention patents in August. The company's patent portfolio now totals 50 applied patents, both domestic and international, with 25 of them granted.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:29 pm

AAPL

BP

BTCUSD

ETHUSD

TSLA

Apple's iPhone 15 launch received a lukewarm response from investors. Cryptocurrencies Bitcoin, Ethereum, and Dogecoin spiked after Franklin Templeton filed for a BTC Spot ETF. Tesla's Chinese rival BYD is seen as a cost-effective contender to Model 3. Elon Musk discussed acquiring Twitter for $44B and his company X's new feature to rival TikTok and Instagram. BP's CEO resigned amid an investigation into personal conduct.

Portfolio Pulse from Akanksha Bakshi

September 13, 2023 | 1:17 pm

MRK

MRNA

Moderna Inc plans to launch up to 15 new products and advance up to 50 mRNA medicines into clinical trials over the next five years. The company expects sales of its respiratory vaccines to range between $8 billion and $15 billion in 2027, with another $10 billion to $15 billion from annual sales of cancer, rare disease, and latent disease medicines it will launch by 2028. Moderna also plans to invest $25 billion in Research and development from 2024 through 2028. In partnership with Merck & Co Inc, Moderna plans to begin a second Phase 3 trial of mRNA-4157, its individualized neoantigen therapy, in combination with Keytruda, for non-small cell lung cancer later this year.

Portfolio Pulse from Vandana Singh

September 13, 2023 | 1:13 pm

S

SentinelOne has launched Singularity RemoteOps Forensics, a new solution that combines forensics evidence with real-time telemetry to provide unified insights into security incidents. This tool is designed to enhance the efficiency and speed of investigation and response activities.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:11 pm

MDGL

Madrigal Pharmaceuticals has announced that its New Drug Application (NDA) for Resmetirom, a treatment for NASH with liver fibrosis, has been accepted and given priority review.

Portfolio Pulse from Bill Haddad

September 13, 2023 | 1:11 pm

GDRX

GoodRx and MedImpact have announced a program to ensure seamless access to affordable prescriptions. The program will automatically compare the benefit and the GoodRx price for a generic medication and deliver the lowest one. The amount paid will be applied to the member's deductible.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 1:07 pm